Purpose: Children with acute lymphoblastic leukemia (ALL) are complicated with cytomegalovirus (CMV) retinitis due to the compromised immune function after chemotherapy. Here, we report a case of cytomegalovirus retinitis in a 4-year-old girl with ALL to emphasize the importance of early diagnosis and intravenous administration of antiviral medication in this group of patients. Case Report: A 4-year-old girl with ALL was diagnosed of fulminant CMV retinitis after chemotherapy. Funduscopic examination revealed perivascular sheathing in pole and peripheral retina of right eye. Large areas of yellowish-white edema, hemorrhage and exudation along the vessels were seen in the superior nasal retina. Few perivascular sheathings were found in peripheral retina without obvious hemorrhage and exudation in left eye. With early diagnosis and prompt intravenous administration of ganciclovir，the lesion of the fundus subsided and the vision was restored over 4 months of follow up period. Conclusions: In summary, CMV retinitis can occur in ALL pediatric patients who receive chemotherapy only, especially in the maintenance stage. With routine follow-up, early diagnosis and intravenous antiviral therapy, these patients may have a good prognosis.
INTRODUCTION
Cytomegalovirus (CMV), a ubiquitous herpesvirus, can cause severe disease with high morbidity and mortality in immunocompromised patients [1] . CMV retinitis is a serious viral eye infection of the retina, commonly in the form of necrotizing retinitis, which can potentially lead to blindness. CMV infection is commonly present in patients with advanced acquired immunodeficiency syndrome (AIDS), patients with immunodeficiency due to other etiologies are highly vulnerable to CMV infection. [2] CM retinitis has been described in ALL patients who received chemotherapy. However, only two cases of CMV retinitis have been reported in ALL children on chemotherapy [3, 4] . Herein, we reported a fulminant CMV retinitis in a 4-year-old girl with ALL on chemotherapy, with an emphasis on early diagnosis and prompt intravenous administration of antiviral medication. DOI: https://doi.org/10.30654/MJCS.10017 Retinal focus of right eye showed healing scar. The blood vessels were white (Figure 4. A-H) . The CD4 T-cell count was 254/μl. Systemic antiviral medication discontinued. There was no evidence of recurrence in 6 months of follow-up. CMV specifically infects T lymphocytes.CMV retinitis is closely associated with the CD4 T-cell counts, which can be used to predict the risk of CMV retinitis [8] . In addition to regular monitoring visual acuity and fundus manifestations in CMV retinitis patients, the count of CD4 T-cell should be detected simutaneously. Therefore, we recommend that CD4 T-cell count should be measured when regular eye examination is performed after acute lymphoblastic leukemia chemotherapy.
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CASE REPORT
We should be on highly cautious of CMV retinitis for the patients whose CD4 T-cell count is low, especially less than 100 /μl, and CMV-DNA is detected.
In our patient, after early diagnosis and early systemic administration of ganciclovir antiviral medication,, CMV retinitis was well controlled.. However, the antiviral therapy of ganciclovir may cause toxicity to other organs. Therefore, the use of intravitreal injection for the treatment of CMV retinitis is recommended. General anesthesia is needed for younger patients to administer intravitreal injection. Both financial cost and risk of complications are high. Unlike our case, it has been reported that the change of perivascular sheathing in the fundus of children with CMV retinitis is rare, and the prognosis is poor. [9] In summary, CMV retinitis is not uncommon in acute lymphoblastic leukemia pediatric patients who receive chemotherapy only, especially in the maintenance stage. With routine follow-up, early diagnosis and intravenous antiviral therapy, these patients have a good prognosis.
